A phase I-II study of the histone deacetylase inhibitor valproic acid plus chemoimmunotherapy in patients with advanced melanoma. - Rocca, A.; Minucci, S.; Tosti, G.; Croci, D.; Contegno, F.; Ballarini, M.; Nolè, F.; Munzone, E.; Salmaggi, A.; Goldhirsch, A.; Pelicci, P. G.; Testori, A.; et al. (British Journal of Cancer, 2009)